Skip to main content

Align Technology, Inc. (ALGN) Stock Analysis

Range Bound setup

SellVALUE-TRAP 1/5High Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Analyst target reached at $177.16 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Invisalign System.

Align Technology designs and markets Invisalign clear aligners and iTero intraoral scanners through two segments: Clear Aligner (~80% of worldwide net revenues in 2025) and Imaging Systems and CAD/CAM Services (~20%). Products are sold directly to orthodontists, general dental... Read more

$177.16+1.4% A.UpsideScore 5.4/10#7 of 25 Medical Instruments & Supplies
Stop $164.98Target $179.97(analyst − 13%)A.R:R 0.2:1
Analyst target$206.86+16.8%14 analysts
$179.97our TP
$177.16price
$206.86mean
$240

Sell if holding. Analyst target reached at $177.16 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Invisalign System. Chart setup: RSI 46 mid-range, Bollinger mid-band. Score 5.4/10, high confidence.

Passes 4/6 gates (clean insider activity, no SEC red flags, earnings proximity 89d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (3/4)
Risks
Concentration risk — Product: Invisalign System
Analyst target reached - limited upside remaining
Leverage penalty (D/E 2.0): -1.5

Key Metrics

P/E (TTM)29.6
P/E (Fwd)14.2
Mkt Cap$12.6B
EV/EBITDA12.8
Profit Mgn10.5%
ROE10.8%
Rev Growth6.2%
Beta1.81
DividendNone
Rating analysts23

Quality Signals

Piotroski F7/9

Options Flow

P/C1.24bearish
IV52%elevated
Max Pain$145-18.2% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductInvisalign System
    10-K Item 1A: 'Our net revenues are primarily dependent on sales of the Invisalign System and iTero intraoral scanners...Invisalign System to continue to represent the majority'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
3.0
Rsi
5.5
Volume distribution (falling OBV)Above 200-MA but MA slope flat
GatesMomentum 1.9<4.5A.R:R 0.2 < 1.5@spotInsider activity: OKNo SEC red flagsEARNINGS PROXIMITY 89d clearSEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive
RSI
46 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $165.40Resistance $200.44

Price Targets

$165
$180
A.Upside+1.6%
A.R:R0.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (1.4% upside)
! Momentum score 1.9/10 — below 4.5 minimum
! Reward/Risk 0.2:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (89d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ALGN stock a buy right now?

Sell if holding. Analyst target reached at $177.16 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: Invisalign System. Chart setup: RSI 46 mid-range, Bollinger mid-band. Prior stop was $164.98. Score 5.4/10, high confidence.

What is the ALGN stock price target?

Take-profit target: $179.97 (+1.4% upside). Prior stop was $164.98. Stop-loss: $164.98.

What are the risks of investing in ALGN?

Concentration risk — Product: Invisalign System; Analyst target reached - limited upside remaining; Leverage penalty (D/E 2.0): -1.5.

Is ALGN overvalued or undervalued?

Align Technology, Inc. trades at a P/E of 29.6 (forward 14.2). TrendMatrix value score: 6.4/10. Verdict: Sell.

What do analysts say about ALGN?

23 analysts cover ALGN with a consensus score of 4.0/5. Average price target: $207.

What does Align Technology, Inc. do?Align Technology designs and markets Invisalign clear aligners and iTero intraoral scanners through two segments: Clear...

Align Technology designs and markets Invisalign clear aligners and iTero intraoral scanners through two segments: Clear Aligner (~80% of worldwide net revenues in 2025) and Imaging Systems and CAD/CAM Services (~20%). Products are sold directly to orthodontists, general dental practitioners, DSOs, and dental labs globally; over 22 million patients worldwide have been treated with the Invisalign System.

Related stocks: WST (West Pharmaceutical Services, I) · MMSI (Merit Medical Systems, Inc.) · RMD (ResMed Inc.) · STVN (Stevanato Group S.p.A.) · ATRC (AtriCure, Inc.)